论文部分内容阅读
近30年来,新的诊断技术和治疗技术、新的化学药物和分子靶向药物不断涌现,对提高胃癌的临床疗效起到了极大的促进作用。在我国,早期胃癌的平均诊断率提高了5%～10%,特别在一些主要医疗中心,早期胃癌诊断率已普遍达到20%以上;对进展期胃癌,由于积极推广以D2根治术为代表的标准术式,淋巴结清扫技术也渐趋规范并进一步改善,加之新型化疗药物和分子靶向药物的应用,总体上提高了进展期胃癌的远期疗效[1-2]。在此情况下,除了继续采用并推广新技术、新药物外,还应在传统治疗理念和工作机制的基础上,作进一步的调整和完善,从而形成由新理念、新机制与新技术、新药物相结合的诊疗新模式,以期达到更好的治疗效果。
In the past 30 years, new diagnostic and therapeutic technologies, new chemical drugs and molecular targeted drugs have been emerging, which have greatly promoted the clinical efficacy of gastric cancer. In China, the average diagnosis rate of early gastric cancer increased by 5% to 10%, especially in some major medical centers, the diagnosis rate of early gastric cancer has generally reached more than 20%; for advanced gastric cancer, due to the active promotion of D2 radical surgery as the representative Standard surgical techniques, lymph node dissection technology has become more standardized and further improved, combined with the new chemotherapeutic drugs and molecular targeted drugs, generally improve the long-term efficacy of advanced gastric cancer [1-2]. Under such circumstances, in addition to continuing to adopt and promote new technologies and new drugs, we should make further adjustments and perfections on the basis of the traditional treatment concept and working mechanism so as to create a new system of new ideas, new mechanisms and new technologies, and new Drug treatment combined with a new model, with a view to achieve better therapeutic effect.